Current status of amyloid-targeting immunotherapies for Alzheimer's disease

被引：9
|
作者：
Tabor, G. Travis [1 ,2 ,3 ]
Holtzman, David M. [1 ,2 ]
机构：
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63130 USA
[3] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO USA
来源：
SCIENCE TRANSLATIONAL MEDICINE | 2023年 / 15卷 / 721期
关键词：
D O I：
10.1126/scitranslmed.adk9993
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Anti-amyloid antibodies are moving from clinical trials into patients to treat early clinical stages of Alzheimer's disease. Anti-amyloid antibodies are moving from clinical trials into patients to treat early clinical stages of Alzheimer's disease.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's disease
    Rosen, Jurij
    Jessen, Frank
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2025, 12 (04):
  • [2] Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease
    Rabinovici, Gil D.
    La Joie, Renaud
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (06): : 507 - 509
  • [3] Amyloid-β-targeting immunotherapies for Alzheimer's disease
    Jin, Yi
    Du, Qiaofei
    Song, Mingjie
    Kang, Ruixin
    Zhou, Jianping
    Zhang, Huaqing
    Ding, Yang
    JOURNAL OF CONTROLLED RELEASE, 2024, 375 : 346 - 365
  • [4] Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease
    Pyun, Jung -Min
    Kang, Min Ju
    Ryoo, Nayoung
    Suh, Jeewon
    Youn, Youn Chul
    Park, Young Ho
    Kim, SangYun
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (03) : 685 - 696
  • [5] Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid β
    Vogt, Anne-Cathrine S.
    Jennings, Gary T.
    Mohsen, Mona O.
    Vogel, Monique
    Bachmann, Martin F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [6] Aducanumab: a review of the first approved amyloid-targeting antibody for Alzheimer’s disease
    Shubhima Grover
    Seema Jain
    Drugs & Therapy Perspectives, 2022, 38 : 443 - 454
  • [7] Amyloid-targeting New Therapies for Alzheimer's Disease: A Health Economics Perspective
    Jonsson, L.
    Wimo, Anders
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2023, 10 (03): : 349 - 352
  • [8] Amyloid-targeting New Therapies for Alzheimer’s Disease: A Health Economics Perspective
    L. Jönsson
    Anders Wimo
    The Journal of Prevention of Alzheimer's Disease, 2023, 10 : 349 - 352
  • [9] Aducanumab: a review of the first approved amyloid-targeting antibody for Alzheimer's disease
    Grover, Shubhima
    Jain, Seema
    DRUGS & THERAPY PERSPECTIVES, 2022, 38 (10) : 443 - 454
  • [10] Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease
    Hu, Yan
    Cho, Min
    Sachdev, Pallavi
    Dage, Jeffrey
    Hendrix, Suzanne
    Hansson, Oskar
    Bateman, Randall J.
    Hampel, Harald
    MED, 2024, 5 (10): : 1206 - 1226
12345